CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT

Monday, May 8, 2017 1 min read

Key Takeaway: CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT

Full Press Release Details

CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT.